Antibiotic Treatments and Patient Outcomes in Necrotizing Enterocolitis.


Journal

American journal of perinatology
ISSN: 1098-8785
Titre abrégé: Am J Perinatol
Pays: United States
ID NLM: 8405212

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 16 7 2019
medline: 17 8 2021
entrez: 16 7 2019
Statut: ppublish

Résumé

This study aimed to examine the impact of different antibiotic treatments on necrotizing enterocolitis (NEC) outcomes. Patient outcomes, including total parenteral nutrition and hospitalization durations, abdominal surgeries, intestinal strictures, and mortality data, were analyzed and compared by various antibiotic groups and treatment durations for 160 NEC patients managed at the Women and Children's Hospital of Buffalo between 2008 and 2016. Fourteen different antibiotics were used for NEC, most commonly ampicillin, gentamicin, and metronidazole (AGM). Medical (vs. surgical) NEC patients more likely received AGM (37 vs. 6%, Antibiotic use for NEC varies substantially without definite outcome differences. Particularly with medical NEC, AGM for ≤10 days had comparable outcomes to other treatments. In light of growing concern for short and longer term adverse effects with early-life antibiotic exposure, narrow-spectrum and shorter course NEC treatment may be preferred.

Identifiants

pubmed: 31307104
doi: 10.1055/s-0039-1693429
doi:

Substances chimiques

Anti-Bacterial Agents 0
Gentamicins 0
Metronidazole 140QMO216E
Ampicillin 7C782967RD

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1250-1257

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Catherine Murphy (C)

Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York.

Jayasree Nair (J)

Division of Neonatology, Department of Pediatrics, University at Buffalo, State University of New York, Buffalo, New York.

Brian Wrotniak (B)

Department of Pediatrics, University at Buffalo, State University of New York, Buffalo, New York.

Emily Polischuk (E)

Department of Pharmacy, John R. Oishei Children's Hospital of Buffalo, Buffalo, New York.

Shamim Islam (S)

Division of Infectious Diseases, Department of Pediatrics, University at Buffalo, State University of New York, Buffalo, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH